Summary
Differentials
Common
- Ascariasis
- Strongyloidiasis
- Schistosomiasis
- Trichinellosis
- Urticaria
- Pemphigus
- Bullous pemphigoid
- Asthma
- Eczema
- Allergic rhinitis
Uncommon
- Clonorchiasis
- Fascioliasis
- Fasciolopsiasis
- Opisthorchiasis
- Filariasis
- Gnathostomiasis
- Toxocariasis
- Paragonimiasis
- Ancylostoma caninum infestation
- Coccidioidomycosis
- Herpes gestationis
- Drug hypersensitivity
- Allergic bronchopulmonary aspergillosis
- Eosinophilic granulomatosis with polyangiitis
- Eosinophilic esophagitis
- Eosinophilic gastroenteritis
- Eosinophilic cellulitis (Wells syndrome)
- Chronic eosinophilic leukemia
- Other leukemias
- Non-Hodgkin lymphoma
- Hodgkin lymphoma
- Nonhematologic malignancy-associated hypereosinophilia
- Lymphocytic variant of hypereosinophilic syndrome
- Idiopathic hypereosinophilic syndrome
- Wiskott-Aldrich syndrome
- Job syndrome
- Hyperimmunoglobulin E syndrome
- Severe combined immune deficiency due to adenosine deaminase deficiency
- Omenn syndrome
- immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome
- Autoimmune lymphoproliferative syndrome (ALPS)
- Loeys-Dietz syndrome
- Comel-Netherton syndrome
- Severe dermatitis, multiple allergies, and metabolic wasting (SAM) syndrome
- Muscular sarcocystosis
- Cystoisospora belli (formerly Isospora belli) infection
- Anisakiasis
- Loiasis
Contributors
Authors
Barbara J. Bain, MBBS, FRACP, FRCPath
Professor of Diagnostic Haematology
St Mary's Hospital Campus
Imperial College London
London
UK
Disclosures
BJB is an author of a number of references cited in this topic.
James Uprichard, MBBS, BSc, PhD, FRCP, FRCPath
Consultant Haematologist
Department of Haematology
St George's University Hospitals NHS Foundation Trust
London
UK
Disclosures
JU is on Bayer, Vifor Pharma, and Octapharma scientific advisory boards; Bayer, Octapharma, Shire, Vifor Pharma, and Daiichi-Sankyo speaker bureaus; is involved in clinical trials associated with Portola, Bayer, Boehringer-Ingelheim, and Daiichi-Sankyo; and has received travel support from Bayer.
Peer reviewers
Jonathan Bernstein, MD
Professor of Medicine
Department of Internal Medicine
Division of Immunology/Allergy Section
University of Cincinnati
Cincinnati
OH
Disclosures
JB is the editor of the Joint Task Force Practice Parameters on Urticaria.
Jan Cools, PhD
Associate Professor
Department of Molecular and Developmental Genetics
Katholieke Universiteit Leuven
Leuven
Belgium
Disclosures
JC is an author of a reference cited in this topic.
Patient leaflets
Asthma in adults: what is it?
Asthma in adults: questions to ask your doctor
More Patient leafletsLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer